Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Salvato in:

Dettagli Bibliografici
Pubblicato in:	Journal for Immunotherapy of Cancer vol. 13, no. 2 (Feb 2025), p. e009352
Autore principale:	Eigentler, Thomas
Altri autori:	Thomas, Ioannis, Samoylenko, Igor, Erdmann, Michael, Heinzerling, Lucie, Ochsenreither, Sebastian, Krauss, Jürgen, Oberoi, Arjun, Robert, Caroline, Lebbe, Celeste, Martin-Liberal, Juan, Koch, Lukas, Richtig, Erika, Terheyden, Patrick, Weishaupt, Carsten, Mohr, Peter, Semiletova, Yulia, Casilda Llacer Perez, Brossart, Peter, Bauernfeind, Franz Georg, Fluck, Michael, Poltoratskiy, Artem, Sekacheva, Marina, Soria, Ainara, Schmitt-Bormann, Beate, Gonzalez, Marina, Heß, Jana, Wengenmayer, Peter, Seibel, Tobias, Koch, Sven D, Quintini, Gianluca, Codó, Paula, Falk, Martin, Schönborn-Kellenberger, Oliver, Gnad-Vogt, Ulrike
Pubblicazione:	BMJ Publishing Group LTD
Soggetti:	Head & neck cancer Biomarkers Squamous cell carcinoma Vaccines Cell death Metastasis Melanoma Peptides Tumors Cancer therapies Immunology Proteins Skin cancer
Accesso online:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Lascia un commento!